It is well known that cardiovascular diseases are the number one mortality cause in the western world. The current treatment using stents is not foolproof. Now, an Israeli Company, BIOrest, has developed a medication which can make recovery from the ...

A new study, co-authored by Australian and American institutes, predicts that microbicides currently being developed to prevent HIV infection in women could lead to enhanced HIV drug resistance, and offer more protection to men. These predictions are based on a ...

Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that neutralize HIV. This discovery is likely to lead ...

The Nobel Assembly at Karolinka Institute is awarding the 2008 Nobel Prize in Physiology or Medicine to Harald zur Hausen of the German Cancer Research Centre in Heidelberg, Germany, Francoise Barre-Sinoussi of the Virology Department of the Institut Pasteur in ...

If you don’t like exercising you’re definitely not alone in your aversion. However, soon there may be a solution for you – in a form of a pill. Scientists from the Salk institute for Biological studies in California have developed ...

Cambridge Consultants, as part of the Continua Health Alliance, has announced the development of the Vena platform. Vena is a single-chip communications solution for health devices, with the capability to provide wired (USB) and wireless (Bluetooth) connectivity to health devices. ...

Pioneering research by UK scientists shows that a new product – Rember – may slow the progress of mild to moderate Alzheimer’s disease by 81% over a year and could offer hope to millions worldwide. Rember is the first drug ...

Do you like being under pressure? Do you enjoy running around like a mouse on a wheel? Think again. Scientists from UCLA have discovered a cellular mechanism linking between stress, aging, and illness. This discovery could potentially help create drugs ...

The Swiss Company Debiotech has developed a tiny insulin pump to deliver accurate drug quantities over a long time. The pump, 65 millimeters in size, sucks the drug from a container and injects it to the body. The device is ...

The San Francisco based biopharmaceutical company Medivation has recently published results of its first pivotal clinical trial of Dimebon in Alzheimer’s disease. Dimebon, a drug formerly approved as an allergy treatment, demonstrated statistically significant improvement over placebo in memory, thinking, ...